|
|
Volumn 29, Issue 1, 2011, Pages 5-6
|
|
Boehringer splashes out on bispecific antibody platforms.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPECIFIC ANTIBODY;
IMMUNOGLOBULIN FRAGMENT;
ANIMAL;
BIOSYNTHESIS;
BIOTECHNOLOGY;
CHEMISTRY;
COOPERATION;
DRUG INDUSTRY;
ECONOMICS;
FINANCIAL MANAGEMENT;
HUMAN;
IMMUNOASSAY;
IMMUNOLOGY;
METHODOLOGY;
MOUSE;
NOTE;
ANIMALS;
ANTIBODIES, BISPECIFIC;
BIOTECHNOLOGY;
COOPERATIVE BEHAVIOR;
DRUG INDUSTRY;
HUMANS;
IMMUNOASSAY;
IMMUNOGLOBULIN FRAGMENTS;
MICE;
RESEARCH SUPPORT AS TOPIC;
|
|
EID: 79955668450
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0111-5 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
